Skip to main content
Premium Trial:

Request an Annual Quote

Norgen Biotek Developing POC MDx Technologies with $821K Award

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canadian biotechnology firm Norgen Biotek today announced a C$800,000 (US$821,000) award from the National Research Council of Canada Industrial Research Assistance Program, which the company will use to develop point-of-care diagnostic technologies.

The technologies, Norgen said, will be directed for use in settings with limited resources. The company will focus its development efforts on non-invasive, urine-based, rapid detection systems for diagnosing sexually transmitted infections and other diseases, such as tuberculosis.

Norgen added that it will be partnering with an unnamed Spanish diagnostic firm in the R&D work.

Based in Thorold, Ontario, Norgen is focused on developing sample preparation kits for DNA, RNA, and protein purification, and diagnostic tools.

"Such funding will help us in the transition of our powerful nucleic acid isolation technology into diagnostics applications," Yousef Haj-Ahmad, president and CEO of Norgen, said in a statement.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.